Results
1
High Growth Stocks
1 companies
argenx
Market Cap: €50.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€804.40
7D
7.0%
1Y
59.6%
